Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived therapies, announces its participation at the International Primary Immunodeficiencies Congress (IPIC) 2025, taking place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback